Skip to main content

Table 2 Comparison of the ovarian reserve markers pre- and post-treatment in each group

From: Dehydroepiandrosterone plus climen supplementation shows better effects than dehydroepiandrosterone alone on infertility patients with diminished ovarian reserve of low-FSH level undergoing in-vitro fertilization cycles: a randomized controlled trial

  The DHEA group P-value The DHEA plus climen group P-value
Pre-treament Post-treatment Pre-treament Post-treatment
AMH (ng/ml) 0.98 ± 0.72 1.24 ± 1.07 0.015 0.90 ± 0.66 1.14 ± 0.79 0.001
FSH(IU/L) 12.93 ± 7.02 10.03 ± 5.48 0.003 11.86 ± 5.29 9.08 ± 5.51 0.001
E2 (pmol/L) 181.53 ± 137.26 113.96 ± 70.00 0.001 160.65 ± 116.90 278.50 ± 135.80 0.000
High-FSH subgroups
AMH (ng/ml) 0.88 ± 0.65 0.99 ± 1.06 0.322 0.68 ± 0.58 0.89 ± 0.75 0.034
FSH (IU/L) 17.35 ± 6.34 11.84 ± 6.45 0.001 15.40 ± 4.00 10.56 ± 6.54 0.001
E2 (pmol/L) 155.70 ± 93.43 122.32 ± 79.44 0.070 120.35 ± 81.91 276.30 ± 139.76 0.000
Low-FSH subgroups
AMH (ng/ml) 1.11 ± 0.78 1.56 ± 1.01 0.002 1.18 ± 0.67 1.45 ± 0.74 0.004
FSH (IU/L) 7.24 ± 1.82 7.69 ± 2.49 0.445 7.13 ± 2.11 7.14 ± 2.87 0.982
E2 (pmol/L) 214.75 ± 174.96 103.21 ± 55.14 0.003 213.37 ± 135.26 281.53 ± 133.33 0.035
  1. Data are presented as mean ± SD (standard deviation) or percentage as appropriate. Subgroups were divided based on a basal FSH level cut-off of 10 mlU/ml
  2. P <0.05 was considered as statistically significant